# Sinovation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sinovation

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.sinovationmed.com
- Total disclosed funding: $57M
- Latest round: Series D (Jul 31, 2023)
- Investors on record: 10

## About

Established 2015 and based in Beijing, China, Sinovation is a medical technology company that focuses on the development of surgical robots. In 2018, the company launched neurosurgery robot products. In 2019, it launched neurosurgery surgery navigation products. Di Wu, the co-founder of the company, once worked in Xuanwu Hospital of Capital Medical University. The company has more than 90 authorized patents, and 7 of its products have obtained the National Class III Medical Device Registration Certificate. In July 2023, Sinovation completed a series D+ funding.

The company's main products include neurosurgery robot products, neurosurgery navigation products, magnetic resonance guided laser ablation treatment systems and medical software. The magnetic resonance guided intracranial laser ablation therapy system (LITT) can enable laser ablation fiber to achieve accurate ablation of deep intracranial lesions under the monitoring of real-time magnetic resonance thermography.

## Funding rounds

- Series D, Jul 31, 2023, $14M — CreditEase Wealth Management, DNV Capital, Tsing Ventures, Huiyu Private Equity Fund Management (Huzhou), Xinda Kunpeng (Shenzhen) Equity Investment Management
- Series D, Dec 26, 2022, $43M — DNV Capital, Co-Win Ventures, Rongquan Investment Group, China-U.S. Green Fund
- Series B, Oct 17, 2019 — China Growth Capital
- Series A, Nov 17, 2017 — Co-Win Ventures, Beijing PINS Medical Co., Ltd.

## Investors

- Co-Win Ventures (https://capitalatlas.ai/funds/co-win-ventures) — Series A, Series D
- Beijing PINS Medical Co., Ltd. — Series A
- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Series B
- DNV Capital (https://capitalatlas.ai/funds/dnv-capital) — Series D
- Rongquan Investment Group — Series D
- China-U.S. Green Fund — Series D
- CreditEase Wealth Management (https://capitalatlas.ai/funds/creditease-wealth-management) — Series D
- Tsing Ventures (https://capitalatlas.ai/funds/tsing-ventures) — Series D
- Huiyu Private Equity Fund Management (Huzhou) (https://capitalatlas.ai/funds/huiyu-private-equity-fund-management-huzhou) — Series D
- Xinda Kunpeng (Shenzhen) Equity Investment Management (https://capitalatlas.ai/funds/xinda-kunpeng-shenzhen-equity-investment-management) — Series D